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ABSTRACT: This work demonstrates how the thermodynamics
of cocrystal formation from the pure, solid coformers can be
directly determined from experimentally obtained calorimetric
data, without involving solubility data or approximations of ideal
solution. For the 1:1 cocrystal between the drug API
sulfamethazine and salicylic acid, the melting temperatures and
associated enthalpies of fusion have been determined for the
coformers in their respective pure solid state and as an equimolar
physical mixture and for the cocrystal, using differential scanning
calorimetry. Heat capacities have been determined for the
respective solid forms and their supercooled melts. The Gibbs
energy for cocrystal formation and the enthalpic and entropic
components have been determined as functions of temperature
through a thermodynamic cycle. The Gibbs energy, enthalpy, and entropy of mixing have been estimated from the thermodynamic
functions for cocrystal formation and fusion of the solid phases. The results show that the Gibbs energy for cocrystal formation is
negative, i.e. the cocrystal is the stable solid phase in relation to a 1:1 mixture of the coformers throughout the temperature interval
from room temperature to the cocrystal melting point, and becomes increasingly negative with increasing temperature. Cocrystal
formation is an endothermic process, driven by the favorable entropy increase, and is accompanied by a 6% increase in molecular
volume. At room temperature, liquid mixing of coformers is found to be weakly exothermic. The results qualitatively align with a
previously reported analysis based on solubility data.
1. INTRODUCTION
As pharmaceutical compounds with poor aqueous solubility
are becoming increasingly common, methods for improving
the pharmacokinetics of these kinds of drugs without affecting
the molecular composition are gaining in importance.
Physicochemical properties that affect the efficiency and
stability of an active pharmaceutical ingredient include the
solubility behavior, dissolution rate, and thermal stability, as
well as properties such as compressibility and hygroscopicity.1
Conventional ways to improve these properties are salt
formation, solubilization, complexation, and micronization.2
Multicomponent crystals (cocrystals) offer an alternative path
with significant benefits, including the potential to increase
aqueous solubility and fine-tune the solubility behavior and
other important properties through judicious coformer
selection.3 The cocrystal approach can also offer opportunities
to exploit intellectual property rights.
As a consequence, gradually more importance is attached to
discovering new cocrystal formulations, also for APIs already
on the market. Recent international guidelines define a
cocrystal as a solid, crystalline material composed of two or
more molecules in the same crystal lattice.4 Part of a
continuum of multicomponent solid phases, also containing
salts and solvates, a proposed definition of a true cocrystal is
that its structure contains a stoichiometric ratio of electrically
neutral molecules whose pure components are solids at room
temperature and pressure.5 Cocrystals can be manufactured by
many different methods. The most common is crystallization
from solution involving cooling or a gradual adjustment of the
solvent composition,1,6,7 while other methods including
grinding, evaporation crystallization, and spray-drying.8−11
Despite the surge in popularity and the accompanying
increase in publications reporting new cocrystal systems,
comparatively little has been reported on the various
thermodynamic aspects of cocrystals in relation to the solid
coformers, which are key to understanding their formation, as
well as their stability and dissolution behavior in solution. In
the present work, the thermodynamics of formation of a 1:1
cocrystal between sulfamethazine and salicylic acid from its
solid components have been explored in depth, by the
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application of differential scanning calorimetry. Sulfamethazine
(SMT), also known as sulfadimidine, is a sulfonamide drug
with antimicrobial and anti-infective properties,12,13 whose
bioavailability is limited by its low solubility. SMT has one
known crystal structure14 but in analogy with many other sulfa
drugs has shown a strong propensity to form cocrystals,13,15
including a 1:1 cocrystal with the coformer salicylic acid (SA)
(Figure 1).
2. THEORY
Consider a cocrystal C, formed from a moles of coformer A
and b moles of coformer B:
a b a bA B A B C+ =F (1)
For a 1:1 cocrystal, a = b = 1. The property determining the
relative stability of a cocrystal in relation to its coformers is the
Gibbs energy change of the reaction in eq 1. In the following,
according to the established terminology for multicomponent
solids,17−21 this is termed the Gibbs energy for cocrystal
formation, ΔformGC. This property is generally defined for the
process in eq 1 with both reactants and product in the solid
state at temperature T:





sΔ = Δ − Δ = − − (2)
Like all Gibbs energy changes, ΔformGC has an enthalpic
(ΔformHC) and an entropic (TΔformSC) component. A negative
ΔformGC signifies that the total process of mixing equal parts of
the solid coformers at a molecular level and forming the
cocrystal structure is thermodynamically favored and is
spontaneous. This process can be envisaged as breaking the
crystal structures A and B to form a supercooled melt, from
which C is subsequently crystallized (solvent-free path), or
alternatively the dissolution of equal parts A and B into a
solution with a composition corresponding to saturation with
respect to C, followed by crystallization of C to restore
equilibrium (solution path).
The relative stability of a cocrystal in relation to its
coformers can be estimated in a number of ways. In an
approximate approach, relative lattice energies of cocrystals
and their crystalline components may be compared. This offers
a method to computationally predict the occurrence of
cocrystals.22,23 However, a method based on lattice energies
neglects the influence of entropy on the propensity for
cocrystal formation, and moreover, computational methods for
calculation of lattice energies often neglect zero-point energies
as well as thermal effects.24,25
ΔformGC can also be estimated experimentally using
solubility data.26−29 By setting the reference state for the
chemical potentials to the respective solid phases, an
expression for the Gibbs energy for cocrystal formation in
terms of activities of A and B in solution can be obtained, as
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+ denote the activities of A and B in the
saturated solutions of pure A and pure B, respectively, and aA
and aB are the activities in a solution at equilibrium with a 1:1
cocrystal. Neglecting the influence of activity coefficients on
the solubilitya routinely used approximation which is strictly
only valid for ideal solutions and dilute solutions obeying
Henry’s lawresults in an expression in terms of the solubility,











where Ks denotes the solubility product for a solution at
equilibrium with the cocrystal, cA
acB
b.30 For the case of a 1:1
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Finally, ΔformGC and its components could be estimated on the
basis of calorimetric data. Zhang et al.19,24 determined
enthalpies for the formation of several cocrystals using
differential scanning calorimetry and back-calculated the
entropy term using ΔformGC obtained from solubility data.
Oliveira et al.21 used data on the enthalpy of solution to
calculate enthalpies for cocrystal formation for several
saccharin-based cocrystals and then obtained ΔformGC using
solubility data. Perlovich31 estimated Gibbs energies for
cocrystal formation by correlating melting temperatures and
Gibbs energies of sublimation. Braun et al.32 estimated ΔformGC
of a crystalline racemic compound of naproxen from a racemic
conglomerate from calorimetric melting data. However, it
appears no study has yet been published in the open literature
reporting a full experimental determination of ΔformGC of a
cocrystal composed of chemically different molecules solely on
the basis of differential scanning calorimetry data, and
moreover no study has reported a calorimetry-based
determination of ΔformGC which specifically accounts for the
contributions from heat capacity.
3. EXPERIMENTAL WORK
Solid sulfamethazine (CAS registry no. 57-68-1, nominal purity
>99%) and salicylic acid (CAS registry no. 69-72-7, nominal purity
>99%) were purchased from Sigma-Aldrich and used with no further
purification. The 1:1 cocrystal was synthesized using solvent drop
grinding as described in a previous publication.33 The solid materials
were characterized by X-ray powder diffraction (XRPD) using an
Empyrean diffractometer (PANalytical, Philips) with Cu Kα1,2
radiation at 40 kV and 40 mA and verified to be identical with the
only previously described crystalline phases of the respective
compounds14,16,34 (XRPD patterns are provided as Supporting
Information). A 1:1 molar ratio physical mixture of the two pure
solid coformers (SMT and SA) was prepared by careful weighing and
gentle mixing of equimolar amounts of separately ground crystal
powders.
The melting temperature, Tm, and the associated enthalpy of
fusion, ΔfusH, of solid sulfamethazine, the 1:1 salicylic acid−
sulfamethazine cocrystal, and a 1:1 physical mixture of the two pure
solid coformers have been determined by differential scanning
calorimetry (DSC). Measurements were carried out on a TA
Instruments Q2000 instrument, using a constant heating rate of 3
K min−1. The heat capacity of the solid states, Cp
s, and melts, Cp
l, of
Figure 1. Molecular structure of sulfamethazine (SMT, left) and
salicylic acid (SA, right).
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salicylic acid, sulfamethazine, and the 1:1 cocrystal have been
determined by temperature-modulated DSC, using a TA Instruments
Q2000 instrument. A modulation period of 100 s, an amplitude of 1
K, and a constant underlying heating rate of 5 K min−1 were used;
these conditions were established as optimal on the basis of
preliminary experiments. Heat capacity data for the solid forms
were collected in an initial heating step. After melting, the heat
capacity of the respective supercooled melts were then obtained in a
second heating step, following a rapid cooling of the pans containing
the melts to a point below the melting temperature but above the
temperatures where recrystallization would occur.
In all DSC experiments, evenly distributed powder samples of
approximately 5 mg were encapsulated in Tzero aluminum pans. The
furnace was purged with nitrogen gas at 50 mL min−1. The instrument
was calibrated for data collection on heating against the melting
properties of indium, and the heat capacity signal was calibrated using
sapphire, with a linear function of heat capacity vs temperature.
Differences in mass between the sample and reference pans were
restricted to ≤0.20 mg in all runs.
Thermogravimetric analysis (TGA) was carried out on the three
pure solid phases using a TA Instruments Q50 instrument. The
furnace was purged with nitrogen gas, and powder samples were
placed in platinum pans and heated to 770 K at a constant heating
rate of 10 K min−1.
4. RESULTS
The extrapolated onset melting temperature and the associated
enthalpy of fusion of sulfamethazine, the 1:1 cocrystal, and the
1:1 physical mixture have been determined, each as averages of
four repeat DSC runs. The data are given in Table 1 together
with data for salicylic acid,35 and representative thermograms
are shown in Figure 2a. The thermogram for the physical
mixture shows a clear endotherm at a temperature significantly
below that of the cocrystal, with some weak residual
endothermic activity extending after the peak. There is no
trace of a melting peak corresponding to the cocrystal in this
thermogram, which indicates complete melting of the physical
mixture without transformation into the cocrystal.
The thermograms of all samples show straight baselines up
to the respective melting endotherms, indicating that no phase
transformation occurred in any of the samples prior to melting.
Reweighing of the sample pans run confirmed that the sample
mass was unchanged after each run. The TGA traces (available
as Supporting Information) show no measurable mass loss,
indicating that the samples were completely dry, until the onset
of melting for SMT, with a gradual mass decrease starting
Table 1. DSC Data for the Solid Phases and Their Respective Melts, Together with Coefficients of Eq 6a
sulfamethazine salicylic acid 1:1 cocrystal 1:1 physical mixture
Melting Point
Tm/K [N] 469.66 ± 0.08 [4] 431.35 ± 0.35
35 [14] 469.52 ± 0.13 [4] 426.05 ± 0.17 [4]
ΔfusH(Tm)/kJ mol−1 36.0 ± 0.44 27.09 ± 0.1735 60.3 ± 1.8 63.5 ± 1.6
ΔfusS(Tm)/J K−1 mol−1 76.7 ± 0.95 62.8 ± 0.3635 128 ± 3.8 149 ± 3.8
Specific Heat Capacity
ks/J K−2 mol−1 0.9057 0.5248 1.4309 -
ms/J K−1 mol−1 46.32 10.49 118.10 -
kl/J K−2 mol−1 0.3051 0.5884 0.8015
ml/J K−1 mol−1 439.40 48.40 576.73
T range (s)/K [N] 278−455 [5] 273−418 [4] 280−438 [4] -
T range (l)/K [N] 416−467 [4] 418−432 [4] 423−468 [4]
aExperimental data are given together with expanded standard uncertainties at the 95% confidence level, obtained from standard errors over N
repeat experiments.
Figure 2. (a) DSC thermograms showing melting endotherms of the cocrystal, the equimolar physical mixture of coformers, and the pure
coformers. (b) Heat capacities of the solids and supercooled melts of the cocrystal and the pure coformers together with linear fits.
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slightly prior to melting for SA and the cocrystal,
corresponding to sublimation in the open pan environment.
The specific heat capacities of the pure solid forms and their
respective melts over a range of temperatures have been
determined as averages of four to five repeat DSC runs, and
fitted to a linear equation of two parameters k and m:
C T kT m( )p = + (6)
As shown in Figure 2b, the Cp(T) curves for all three solids
and their respective melts are all to a good approximation
linear over the recorded temperature intervals (R2 values
exceeding 0.99 with the exception of the melt of
sulfamethazine, for which R2 = 0.97). The coefficients k and
m are given in Table 1 together with the temperature ranges of
the experimental data. Please note that, with respect to the
units for the cocrystal and the physical mixture, 1 mol consists
of 1 mol of SMT and 1 mol of SA. The experimental data are
given in the Supporting Information.
The heat capacity for the cocrystal exceeds the combined
heat capacities of the coformers throughout the evaluated
temperature range, for both the solid and the melt; for the
solids at room temperature, the difference is 61 J K−1 mol−1, or
about 13%, and for the melts at the melting temperature of the
cocrystal, the difference is 46 J K−1 mol−1 (5%). Likewise, the
enthalpy and entropy of fusion of the physical mixture exceeds
the combined respective values of the coformers, albeit at a
different temperature.
5. EVALUATION AND DISCUSSION
5.1. Estimating the Binary Phase Diagram of the
System SMT−SA from DSC Data. The thermogram of the
1:1 physical mixture in Figure 2a exhibits an endotherm
composed of an initial main sharp peak followed by an
extended weak tail of endothermic activity. This indicates that
the composition of the physical mixture does not exactly
correspond to the eutectic between SMT and SA. The main
peak is caused by melting of the eutectic, and the residual tail is
the gradual melting and mixing (i.e., dissolution) of the
remaining pure component (SMT) along its liquidus curve.
The absence of any exothermal activity and of any additional
melting peak indicates that the melting is not accompanied by
a recrystallization into the cocrystal.
By analysis of the DSC data, a tentative binary phase
diagram of the system has been constructed (Figure 3). It is
clear from the figure that the cocrystal exhibits congruent
melting behavior and is the stable solid phase at an equimolar
composition.
The phase diagram is based on the experimentally
determined points 1−4 and the estimated locations of points
5 and 6, as follows. Point 1 is the melting point of pure SA.
Point 2 is the melting point of pure SMT. Point 3 is the
congruent melting point of the 1:1 cocrystal. Point 4 is the
melting temperature of the metastable eutectic between SA
and SMT. For the determination of point 4, the extrapolated
onset temperature of the main peak of the 1:1 physical mixture
was taken. Point 5 is the intersection of the (metastable)
liquidus of SMT at x = 0.5. For the location of point 5, the
temperature has been estimated from the thermograms of the
1:1 physical mixture. The resulting value obtained is 435.3 ±
0.24 K, which is 9.3 K above the eutectic temperature. Point 6
is the eutectic point. For the location of point 6, the
composition was estimated on the basis of fractional
integration of the collected thermograms of the 1:1 physical
mixture, according to the principle of the lever arm rule. The
area of the residual part of the peak is compared to the total
area, with the areas weighted using the pure component
enthalpies of fusion (of pure SMT and of the 1:1 mixture,
respectivelythis treatment entails assuming that the con-
tributions from differences in liquid mixing can be neglected).
The resulting value obtained is xSMT = 0.44.
The liquidus of SMT has been estimated on the basis of
points 2, 5, and 6, and the liquidus of SA is plotted as a line
from point 1 to point 6. Please note that the curvature of the
liquidus of the cocrystal has not been determined, and the line
shown in Figure 3 is only a schematic. Points A and B
represent the intersections of the liquidus of the cocrystal with
the respective liquidi of the pure components, and the
locations of these points have not been determined.
5.2. Estimating the Gibbs Energy for Cocrystal
Formation from DSC Data. Estimation of the thermody-
namic functions of cocrystal formation from solid components
can be accomplished indirectly by analysis of a path in a
suitable thermodynamic cycle. A complete thermodynamic
cycle for the solvent-free path from solid A + solid B to solid C
at temperature T is depicted in Figure 4 for a 1:1 cocrystal.
This cycle takes into account phase transitions, mixing and
heat capacity contributions.
With reference to Figure 4, step 1 is the heating of a physical
mixture of stoichiometrically correct proportions of the solid
coformers to the melting temperature of the physical mixture,
Tm,A+B, where the mixture melts, step 2. Step 3 is the heating of
the molten mixture to the melting temperature of the cocrystal
C. Step 4 is the crystallization of C from the melt at the
melting point of the cocrystal, and step 5 is the subsequentFigure 3. Phase diagram of the system SA−SMT.
Figure 4. Thermodynamic cycle for cocrystal formation.
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cooling of solid cocrystal C back to the starting temperature. If
the composition of the physical mixture corresponds to the
eutectic, Tm,A+B is equal to the eutectic temperature. At this
temperature, melting would then be accompanied by a
simultaneous liquid mixing of A and B molecules, contributing
to both the enthalpy change and the entropy change of the
total phase transition from solid to liquid, step 2. However, if
as in the current case the composition of the physical mixture,
and hence the cocrystal, differs from the eutectic composition,
melting and mixing of the eutectic will occur at the eutectic
temperature until one of the components is consumed, and
with further heating the remainder of the other component (in
this case SMT) will gradually melt and mix (dissolve) into the
solution until the system composition corresponds to the
liquidus of this component (cf. point 5 in Figure 3).
The Gibbs energy change for the process as outlined in
Figure 4 is ΔformGC = ΔformHC − TΔformSC. The total changes
in enthalpy, H, and entropy, S, for steps 1 through 5 become
H T C C T
H T C T
H T C T
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Since heat capacity data are frequently not available for all
phases, the influence of the heat capacity terms in estimation of
thermodynamic functions from DSC data is often neglected or
simplified: e.g., approximated with a constant value such as the
entropy of fusion at Tm.
36 However, the temperature
dependence of the heat capacity can often be a significant
contribution to the total temperature dependence of the
enthalpy and entropy of a process and accordingly has to be
adequately accounted for. In similarity to numerous other
organic condensed phases,37,38 the heat capacity curves of the
phases considered in this work all to a good approximation
exhibit a linear temperature dependence over the temperature
ranges investigated. Assuming that this linear temperature
dependence holds over the respective temperature ranges
involved, the integrals in eqs 7 and 8 can be solved analytically
using the coefficients in Table 1.
For steps 2 and 4, the experimentally determined values of
the enthalpy and entropy are reported in Table 1. For steps 1,
3, and 5, the values of the integral terms are obtained by
inserting the appropriate coefficients listed in Table 1 into eq 6
and solving. (A denotes sulfamethazine, ’ salicylic acid, and C
the 1:1 cocrystal.) With respect to step 2, it is assumed that the
melting and mixing occurs in a single step at the
thermodynamic equilibrium temperature for the combined
process. With respect to the heat-capacity-dependent steps 1,
3, and 5, it is assumed that the heat capacities depend linearly
on temperature over the temperature ranges covered by the
respective steps in Figure 4 and hence for the cocrystal that the
linear temperature dependence can be extrapolated slightly
outside the experimental temperature range. In this work, all
heat capacities in eqs 7 and 8 have been shown to exhibit a
clear linear temperature dependence over the respective range
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Estimated values of ΔformGC and its enthalpic and entropic
components at 298 K together with the respective contribu-
tions from the steps in Figure 4 are given in Table 2 for the 1:1
SMT-SA cocrystal. Estimated uncertainties are based on an
analysis of the data, as expounded upon in the Supporting
Information. Notably, because of the inherent correlation
between the enthalpy and entropy terms (enthalpy−entropy
compensation), the uncertainties of these terms are correlated,
and consequently the uncertainty in the Gibbs energy becomes
smaller than the uncertainties of the enthalpic and entropic
component terms.
Table 2. Gibbs Energy, Enthalpy, and Entropy for the
Formation of the 1:1 Cocrystal at 298 K, Together with
Terms of Eqs 7 and 8, with Uncertainties at the 95%
Confidence Level
stepa ΔH/kJ mol−1 TΔS/kJ mol−1 ΔG/kJ mol−1
1 73.6 ± 1.6 60.6 ± 1.4 13.0 ± 0.29
2 63.5 ± 1.6 44.4 ± 1.1 19.1 ± 0.48
3 40.7 ± 0.91 27.1 ± 0.60 13.6 ± 0.30
4 −60.3 ± 1.8 −38.2 ± 1.1 −22.0 ± 0.65
5 −114.4 ± 2.6 −89.1 ± 2.0 −25.3 ± 0.56
total 3.1 ± 4.0 4.8 ± 2.9 −1.7 ± 1.1
aRelating to Figure 4 and eqs 7 and 8.
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The approach for estimating the thermodynamic functions
of cocrystal formation used here is dependent on a few key
conditions and assumptions. One condition for using the
thermodynamic cycle in Figure 4 is that the cocrystal does not
form before or during melting of the physical mixture. This
kind of behavior, which has been reported for other cocrystals
in the literature,19,24 seems to be promoted by a gentle
treatment of component solids, in particular avoiding
cogrinding,39 but its occurrence is likely very system
dependent.
Another assumption is that the equimolar physical mixture
will melt completely in a single step, as it would at the eutectic
composition. As shown in Figure 3 and discussed earlier, the
eutectic composition (xSMT = 0.44) differs from the cocrystal
composition. Hence, only part of the total enthalpy and
entropy change in step 2 occurs at the eutectic temperature
(melting and mixing of the eutectic), while the remainder is
spread out over the temperature range from the eutectic to the
liquidus: i.e., between points 5 and 6 in Figure 3. This also has
an effect on the integrations in step 3 over the same
temperature range as the fraction and the composition of the
liquid changes. In terms of enthalpy, all of this is captured in
the integration of the endotherm to obtain the total enthalpy.
In terms of entropy, however, there will be errors emanating
from assuming that the total heat transfer for the melting and
mixing occurs at the eutectic temperature and from the heat
capacity integration.
Through integration of the main peak and the residual tail of
the thermograms of the physical mixture, it is estimated that
approximately 85% of the total enthalpy change of the event is
derived from the eutectic melting and 15% from the residual
melting of SMT. As the difference in temperature between the
eutectic and the liquidus compositions (points 4 and 5 in
Figure 3) is estimated to be below 10 K, the error is expected
to be fairly limited. An estimate of the maximum possible
magnitude of this error can be obtained by comparing the
entropy value obtained with the current assumption (in Table
2) with the value that would be obtained by assuming that all
the SMT in excess of the eutectic composition melts and mixes
with the solution at the temperature in point 5, i.e. assuming
that all the heat transfer for this residual part of the melting
and mixing process takes place at the highest possible
temperature, and integrating the heat capacities accordingly.
The resulting maximum estimate of the error in the entropy
term is 0.4 kJ mol−1, or 8% in relative terms. As the heat
transfer occurs gradually over the estimated 9.4 K between
points 4 and 5, the real error will likely be smaller. Please note
that this error is in addition to the uncertainties given in Table
2. For comparison, the ideal entropy term for random
equimolar mixing of two components, RT ln 2, is equal to
1.7 kJ mol−1.
ΔformGC, ΔformHC, and TΔformSC are shown as functions of T
in Figure 5. As shown in the figure, the estimated Gibbs energy
for cocrystal formation is negative throughout the entire
temperature interval evaluated: i.e., the cocrystal is stable in
relation to the physical mixture and formation of the cocrystal
from its solid components is thermodynamically favorable.
This stability increases (the Gibbs energy term becomes
increasingly negative) with increasing temperature, from a
value of −1.7 kJ mol−1 at room temperature to a value of −7.0
kJ mol−1 at the melting point of the cocrystal. The enthalpic
term is strongly positive, however, signifying that cocrystal
formation is an endothermic process and that the total cost of
breaking A−A and B−B bonds between the pure components
exceeds the gain of forming A−B bonds in the cocrystal lattice.
The process of cocrystal formation is thus driven by the
accompanying increase in entropy. This has been suggested to
be a more common situation than previously understood.24,25
Since the enthalpy change is positive, it may be assumed that
with further decrease in temperature, and accompanying
diminishing of the entropy term, cocrystal formation will at
some point become unfavorable. This would be somewhat
analogous to the case of enantiotropic polymorphism, where a
spontaneous, endothermic transformation on heating indicates
the existence of a transition point at a lower temperature. As
shown in Figure 5, however, such a transition point is likely to
be located at a very low temperature. For comparison, the
reported 1:1 cocrystal between celecoxib and nicotinamide has
a confirmed transition point located between 4 and 25 °C.24
On comparison of the numerical values of the enthalpy and
entropy terms obtained for the five steps of the thermody-
namic cycle at room temperature (Table 2), a few noteworthy
observations can be made. First of all, the total enthalpy and
entropy terms clearly are small sums of large numbers, with all
five steps contributing with numbers of the same order of
magnitude. With regard to the enthalpy terms, steps 2 and 4
are responsible for the major part of the total enthalpy for
cocrystal formation (86%) with the contributions from heat
capacity (steps 1, 3, and 5) to a large extent canceling out, as
expected. With regard to the entropy terms, however, the
contributions from the heat capacity terms are fairly significant
(35% of the magnitude of the sum of steps 2 and 4), and with
opposite sign, partially counteracting the large sum of
contributions from steps 2 and 4. In terms of Gibbs energy,
the sum of steps 2 and 4, corresponding to ΔformGC without
accounting for heat capacity differences, is −2.9 kJ mol−1
(standard uncertainty of 0.25) while the component of
ΔformGC stemming purely from heat capacity differences
between the phases is +1.2 kJ mol−1 (42% of the magnitude
of the sum of steps 2 and 4, albeit with a fairly large standard
uncertainty of 0.63). For ΔformGC, neglecting all contributions
from heat capacity results in an error of 71%. This stresses the
importance of including heat capacity terms in estimating
thermodynamic properties.
In a previous contribution33 we estimated values for the
thermodynamic functions of formation of the 1:1 SMT-SA
cocrystal using solubility data in acetonitrile. Using eq 5 and
data in acetonitrile (a congruently dissolving system), the value
of ΔformGC at 283 K was estimated as −5.7 kJ mol−1, becoming
increasingly negative with increasing temperature. Using
approximated solubility data in the solvents methanol and a
7/3 (v/v) DMSO/methanol mixture, ΔformGC values at 283 K
of −6.0 and −6.8 kJ mol−1 were obtained. The value of
Figure 5. ΔformG, ΔformH, and TΔformS vs T for the 1:1 cocrystal.
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ΔformGC at 283 K estimated using calorimetric data is −1.5 kJ
mol−1 (estimated uncertainty of ±1.2 kJ mol−1 at the 95%
confidence level). Hence, even when the uncertainties in the
calorimetric determination emanating both from experimental
factors and the necessary assumptions introduced are allowed
for, the values of ΔformGC obtained using solubility data are still
larger in magnitude than the value obtained in the present
work. A reasonable hypothesis is that a non-negligible part of
the statistically significant difference is caused by the
approximation of activities with concentrations in the
solubility-based method. This approximation entails neglecting
all dependence of the activity coefficient of each of the
components on (i) the concentration of that particular
component in the solution as well as (ii) the presence and
concentration of the third componentthe other coformer.
This is a common approximation, which may be expected to
work well for systems forming solutions that are close to ideal
but which could lead to significant errors for systems where the
activity coefficients clearly deviate more from unity. However,
it is notable that despite the deviation between the sets of
absolute values of the thermodynamic properties obtained with
the two methods, the analyses agree qualitatively with respect
to the main findings: viz., (i) that the formation of the cocrystal
from the pure components is thermodynamically favorable, (ii)
that the thermodynamic stability of the cocrystal increases with
increasing temperature, and (iii) that the cocrystal formation is
an entropy-driven process.
Zhang et al.19 found that, for almost all cocrystals containing
nicotinamide, the molecular volume in the crystal lattice is
larger than the sum of the volumes occupied by the coformer
molecules in their respective crystal lattice. Perlovich18
investigated the connection between this increase in molecular
volume and the entropy for cocrystal formation, and found fair,
positive correlations for cocrystals of several APIs with various
coformers. If one molecule of cocrystal C is defined as one






















where Vcell denotes the unit cell volume and Z the number of
molecules in the unit cell. For the present cocrystal system,
using data from the Cambridge Structural Database for the
structures with refcodes SLFNMD10 (SMT), SALIAC12 (SA)
and GEYSAE (the cocrystal), the increase in molecular volume
upon cocrystal formation was calculated according to eq 11.
No correction for thermal expansion is required, as the chosen
structures were all determined at room temperature. For the
1:1 cocrystal, the increase in volume is +27.3 Å3/molecule,
corresponding to 6%. Given the positive TΔformSC term of 4.8
kJ mol−1 at 298 K, the 1:1 SMT-SA cocrystal behaves
qualitatively like the systems in Perlovich’s data set.18 A
comparison of the crystal structures reveals that the SMT
molecule participates in additional hydrogen-bonding inter-
actions in the cocrystal in comparison to that in its pure
component structure. It is plausible that the additional
hydrogen bonding could form part of the explanation why
the cocrystal has a more open structure than the pure
component crystals. Indeed, similar observations have been
made for nicotinamide−mandelic acid cocrystals.23
5.3. Quantifying the Gibbs Energy of Equimolar
Mixing. The Gibbs energy of fusion of a pure solid phase as a
function of T, ΔfusG, can be experimentally estimated using
DSC data.40 This property is related to the activity of the pure
solid phase, with the pure supercooled melt as the reference
state, and hence to the activity of the respective phase in a
saturated solution (often called the ideal solubility). The
process of experimentally determining ΔfusG entails accurately
measuring the melting temperature, Tm, the associated
enthalpy of fusion, ΔfusH(Tm), and the specific heat capacities
of both the solid and the melt as functions of T. The Gibbs
energy for the process is ΔfusG = ΔfusH − TΔfusS. If the heat
capacities can be approximated as linear functions of
temperature (eq 6), the enthalpy and entropy components
become
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(13)
Combining the Gibbs energies of fusion of the three solid
phases results in a value which can be interpreted as an
estimate of ΔformGC where contributions from equimolar
liquid−liquid mixing of A and B are neglected:
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G G G G G G
G G














Δ + Δ − Δ
= − + − + −
= Δ − Δ (14)
On rearrangement, an expression is obtained that allows the
Gibbs energy of mixing of equimolar amounts of melts of pure
A and pure B to be obtained from the Gibbs energies for
cocrystal formation and fusion:
G G G G Gmix form C fus A fus B fus CΔ = Δ − Δ − Δ + Δ (15)
The expression can be evaluated at any temperature, and can
be used analogously for the enthalpy and entropy components.
For the 1:1 SMT-SA cocrystal, estimated values of the mixing
terms at 298 K are ΔmixG = −1.7 kJ mol−1, ΔmixH = −0.9 kJ
mol−1, and TΔmixS = 0.8 kJ mol−1. In other words, liquid
mixing of equal amounts of SMT and SA is an important,
weakly exothermic process at room temperature. Formation of
the cocrystal from its solid components is an endothermic
process with a large entropy increase, however.
Direct experimental measurement of the Gibbs energy of
mixing of the two supercooled melts A and B is nontrivial. For
an ideal mixture, the enthalpy of mixing is zero, and the Gibbs
energy is given by the entropy of complete random mixing of
equal parts of A and B molecules with identical size and
geometry, ΔmixidS:
G T S RT ln 2mix
id
mix
idΔ = − Δ = − (16)
The ideal Gibbs energy of mixing amounts to −1.7 kJ mol−1 at
room temperature. The ideal entropy term for random
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equimolar mixing (1.7 kJ mol−1) is somewhat higher than the
entropy of mixing term for the 1:1 SMT-SA cocrystal. The
results suggest that the liquid mixture could feature some
degree of order in comparison to a random mixture, especially
given the fact that molecular size differences are expected to
result in a positive excess entropy contribution.41 Because of
compensation from the negative enthalpy term, however, the
Gibbs energy of mixing is almost identical with the ideal value.
It is notable that, in spite of the fact that the solid cocrystal is
an ordered 1:1 mixture, the entropy of cocrystal formation
from pure solid coformers significantly exceeds the entropy of
mixing of an ideal liquid.
If the thermodynamic analysis is carried out neglecting all
heat capacity terms, estimated values of the mixing terms at
298 K become ΔmixG = −2.4 kJ mol−1, ΔmixH = 0.4 kJ mol−1,
and TΔmixS = 2.9 kJ mol−1. The corresponding values for
cocrystal formation at 298 K, neglecting heat capacity terms,
become ΔformGC = −2.9 kJ mol−1, ΔformHC = 3.3 kJ mol−1, and
TΔformSC = 6.2 kJ mol−1.
6. CONCLUSIONS
The present study demonstrates how calorimetry-based values
of the Gibbs energy, enthalpy, and entropy of cocrystal
formation from the pure solid coformers can be obtained. The
Gibbs energy, enthalpy, and entropy for the formation of the
1:1 cocrystal between sulfamethazine and salicylic acid are
reported as functions of temperature. The Gibbs energy term is
negative from room temperature to the cocrystal melting point,
becoming increasingly negative with increasing temperature,
showing that the cocrystal is the stable form in a 1:1 mixture of
the coformers throughout the temperature interval. At room
temperature, the Gibbs energy term is estimated as −1.7 kJ
mol−1. Both the enthalpic and entropic component terms are
positive, at 298 K estimated as 3.1 and 4.8 kJ mol−1,
respectively, showing that cocrystal formation is endothermic
and is driven by the entropy increase. Cocrystal formation is
associated with a 6% increase in molecular volume. The Gibbs
energy, enthalpy, and entropy of fusion of the respective pure
solid phases have been determined and used to estimate the
thermodynamic functions of liquid mixing of equimolar
amounts of coformer melts. Equimolar coformer mixing in
the liquid state is a weakly exothermic process at room
temperature, with the Gibbs energy of mixing estimated to
−1.7 kJ mol−1, very close to the ideal value.
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Conceica̧õ, A. C. L.; Minas da Piedade, M. E. Energetics of glycine
cocrystal or salt formation with two regioisomers: fumaric acid and
maleic acid. Cryst. Growth Des. 2019, 19, 5054.
(30) Nehm, S. J.; Rodríguez-Spong, B.; Rodríguez-Hornedo, N.
Phase solubility diagrams of cocrystals are explained by solubility
product and solution complexation. Cryst. Growth Des. 2006, 6, 592.
(31) Perlovich, G. L. Thermodynamic characteristics of cocrystal
formation and melting points for rational design of pharmaceutical
two-component systems. CrystEngComm 2015, 17, 7019.
(32) Braun, D. E.; Ardid-Candel, M.; D’Oria, E.; Karamertzanis, P.
G.; Arlin, J.-B.; Florence, A. J.; Jones, A. G.; Price, S. L. Racemic
naproxen: a multidisciplinary structural and thermodynamic compar-
ison with the enantiopure form. Cryst. Growth Des. 2011, 11, 5659.
(33) Ahuja, D.; Svar̈d, M.; Rasmuson, Å. C. Investigation of solid−
liquid phase diagrams of the sulfamethazine−salicylic acid co-crystal.
CrystEngComm 2019, 21, 2863.
(34) Bacon, G. E.; Jude, R. J. Neutron-diffraction studies of salicylic
acid and α resorcinol. Z. Krist. - Cryst. Mater. 1973, 138, 19.
(35) Nordström, F. L.; Rasmuson, Å. C. Solubility and melting
properties of salicylic acid. J. Chem. Eng. Data 2006, 51, 1668.
(36) Neau, S. H.; Bhandarkar, S. V.; Hellmuth, E. W. Differential
molar heat capacities to test ideal solubility estimations. Pharm. Res.
1997, 14, 601.
(37) Svar̈d, M.; Rasmuson, Å. C. (Solid + liquid) solubility of
organic compounds in organic solvents − correlation and
extrapolation. J. Chem. Thermodyn. 2014, 76, 124.
(38) Neau, S. H.; Flynn, G. L. Solid and liquid heat capacities of n-
alkyl para-aminobenzoates near the melting point. Pharm. Res. 1990,
07, 1157.
(39) Yamashita, H.; Hirakura, Y.; Yuda, M.; Teramura, T.; Terada,
K. Detection of cocrystal formation based on binary phase diagrams
using thermal analysis. Pharm. Res. 2013, 30, 70.
(40) Svar̈d, M.; Valavi, M.; Khamar, D.; Kuhs, M.; Rasmuson, Å. C.
Thermodynamic stability analysis of tolbutamide polymorphs and
solubility in organic solvents. J. Pharm. Sci. 2016, 105, 1901.
(41) Lichtenthaler, N. R.; Abrams, D. S.; Prausnitz, J. M.
Combinatorial entropy of mixing for molecules differing in size and
shape. Can. J. Chem. 1973, 51, 3071.
Crystal Growth & Design pubs.acs.org/crystal Article
https://dx.doi.org/10.1021/acs.cgd.9b01253
Cryst. Growth Des. XXXX, XXX, XXX−XXX
I
